List of posters

Atherosclerosis

P-01
Serum chemerin and fibroblast growth factor-21 levels in acquired aorta valve stenosis patients

J. Lurins, A. Visocka, G. Krievina, V. Mackevics, P. Tretjakovs

Diabetes

P-02
Can a diabetes affect atherosclerosis?

D. Gabrielyan, L. Gabrielyan, M. Ivanov

P-03
Gliflozin as a possible cause of severe metabolic disorder – case report

M. Protuš, J. Kopecký, E. Uchytilová, P. Wohl

P-04
Lipid disorders in patients with diabetic foot – efficacy of therapy and relation to amputation and mortality

A. Nemcova, A. Jirkovska, M. Dubsky, R. Bem, V. Fejfarova, V. Woskova, A. Pysna, J. Skibova

P-05
Lipid modification in type 1 diabetic patients

S. Savla

P-06
Prevalence of diabetic neuropathy among patients with type 2 diabetes mellitus

Z. S. Akbarov, G. A. Khaidarova, N. N. Maksutova, F. A. Takhirova

P-07
The impact of inherited thrombophilia on the effect of cell therapy of critical limb ischemia in diabetic patients

M. Dubsky, A. Jirkovska, L. Pagacova, R. Bem, A. Nemcova, V. Fejfarova, A. Pysna, K. Navratil

General internal medicine

P-08
A Retrospective Study on Poisoning Deaths in District General Hospital (DGH) Ampara, Sri Lanka

N. M. Hettiarachchi, S. R. Manilgama, R. Sampath, N. Munaweera, S. Kumara

P-09
A Review of Fixed Drug Eruption due to Fluconazole

B. Mistry, J. Beecker

P-10
Cardiac complications in patients who underwent radical cystectomy

M. R. Atabegashvili, D. P. Kotova

P-11
Changes in the levels of cytokines in course of autoimmune hepatitis

D. R. Akberova, D. I. Abdulganieva, A. K. Odintsova, E. Martynova

P-12
Co-existent Miliary Tuberculosis and Non-Hodgkin's Lymphoma – A Case Report

A. Ah-Moye, I. Ferreira, S. Sasikumar

P-13
Have electronic drug charts made prescribing intravenous fluids more dangerous? A quality improvement project improving the safety of intravenous prescription and administration using an electronic system

M. Geddes-Barton, K. Florman, D. Alexander

P-14
Pericardial Effusion: A Cause Beyond the Obvious

G. Vasconcelos, C. Couto, T. Esteves Rodrigues, P. Matos, L. Torres, A. Castro, M. Mesquita

P-15
Psoriasis – unwanted consequence of anti TNF alpha therapy

E. Strujić, S. Aligrudić, D. Pravilović Lutovac

P-16
Rhabdomyolysis and Wernicke-Korsakoff Syndrome – a clinical case

J. Andrade, J. Barradas, V. Romão, A. Lemos, A. Monteiro

P-17
Secondary failure of etanercept therapy in case of good drug level and anti-drug antibodies absence

R. Međedović, E. Strujić, A. Međedović, N. Miketić, D. Pravilović Lutovac

P-18
Spontaneous coronary artery dissection

I. Simkova

P-19
Tuberculosis during infliximab therapy – latent infection activation or unwanted therapy consequence?

R. Međedović, E. Strujić, A. Međedović, N. Miketić, D. Pravilović Lutovac

P-20
Unrecognized and untreated chronic hypoxia – case report

E. Strujić, Z. Vukčević

Heart failure

P-21
Psychoemotional changes at chronic heart failure

S. A. Маtskevich, O. A. Barbuk, M. I. Belskaya

P-22
The study of neurohumoral factors in patients with chronic heart failure

N. A. Nuritdinov, D. D. K. Avezov

Hyperlipidemia and dyslipidemia

P-23
Associations between equivalent radiation dose and blood lipids

A. S. Kerimkulova, A. M. Markabayeva, L. M. Pivina, A. S. Ospanova

P-24
Generalized Lipodystrophy as a Rare Cause of Heart Failure

I. Refatllari, A. Banushi, S. Husi, F. Toti, A. Goda

P-25
The analysis of HDL-cholesterol quantity among middle aged Lithuanian adults

S. Kutkienė, Ž. Petrulionienė, A. Laucevičius, J. Staigytė, A. Šaulytė, E. Rinkūniene, V. Dženkevičiūtė

P-26
The dynamics of serum lipid profile among middle aged Lithuanian adults with dyslipidemia from 2009 to 2015

S. Kutkienė, Ž. Petrulionienė, A. Laucevičius, J. Staigytė, A. Šaulytė, E. Rinkūnienė, V. Dženkevičiūtė

Hypertension

P-27
Assessment of factors for adherence to treatment in hypertensive patients

L. B. Dyussenova, L. M. Pivina, A. S. Kerimkulova, T. I. Belickina

P-28
Blood pressure components and lipids: acquainted traits of cardiovascular disease development

E. V. Pello, T. V. Kouznetsova, Y. P. Nikitin, J. A. Staessen

P-29
Mortality rates by ethnicity among patients suffering from hypertension

A. S. Kerimkulova, V. R. Veber, L. G. Proshina, M. P. Rubanova

Intensive care

P-30
Ethical aspects of enrolling cardiac arrest victims into a research project

T. Sudová, J. Bělohlávek, M. Zvěřová

Metabolic syndrome

P-31
Antihypertensive therapy using two free dosed combination of drugs with calcium channel blocker and angiotensin receptor blocker in patients with metabolic syndrome

A. Alyavi, B. Alyavi, J. Uzokov

P-32
Correction of infectious-inflammatory process in experimental burn disease of stage septic toxaemia

N. M. Chornenka

P-33
The Metabolic syndrome and Lipids

E. Janeková, J. Babjaková, Ľ. Argalášová

Nephrology

P-34
Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients-single center experience

Z. Dimitrijevic, P. Vesovic, B. Mitic, M. Vucic

Rheumatology and CVD

P-35
Cardiac Involvement in Systemic Sclerosis

M. Lezha, Erv. Rapushi, A. Banushi

P-36
Cryoglobulinemic vasculitis in a Systemic Lupus Erythematosus patient

Erv. Rapushi, V. Salko, A. Zoto, T. Backa, D. Ruci, L. Nuhaj, A. Perolla, A. Doko, I. Refatllari, Eri. Rapushi

P-37
Electrophysiological remodeling of the heart in patients with ankylosing spondylitis

L. I. Feiskhanova, A. A. Nigmatyanova, E. Gutieva

Stroke

P-38
Secondary Prevention Following Acute Ischaemic Stroke or Transient Ischaemic Attack (TIA) in Hospital

A. Ah-Moye, S. Y. Lee

Varia

P-39
A Doctor’s Dilemma Solved by the Patient

E. Hasani, I. Refatllari, R. Hasani, A. Banushi

P-40
Analysis of drug induced liver injury at internal department

M. Szantova, Z. Durkovicova, J. Sedlacko

P-41
Experimental model of an acid esophagus burn and its main clinical biochemical parameters

T. V. Koval, T. V. Ishchuk, Y. B. Raetska, O. M. Savchuk

P-42
Chromosome 15 breakage: A strongly possible cause of both ostium secundum atrial septal defect and acute promyelocytic leukemia in a 22 years old female

A. Perolla, A. Banushi, A. Demiraj, A. Babameto

P-43
Role of mycobacterium tuberculosis MPT63 and MPT83 antigens in mechanisms of immune cells activation in vitro

A. Siromolot, O. Oliinyk, D. Kolibo

P-44
The impact of CYP4F2 G1347A genotype on patients` plasma metabolic activity after stent implantation

V. Zvikas, V. Tatarunas, V. Skipskis, V. Jakstas, V. Lesauskaite

HOSTED BY

ČIS

IN COOPERATION WITH

ScreenPro FH

ENDORSED BY

EFIM